Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder
Open Access
- 20 September 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Dental Sciences
- Vol. 17 (2), 659-665
- https://doi.org/10.1016/j.jds.2021.09.020
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare
- Ministry of Science and Technology, Taiwan (110-2314-B-195-015-MY3, MOHW110-TDU-B-211-144019, MOST 108-2314-B-010-014)
- Mackay Memorial Hospital (MMH-E-108-12)
This publication has 37 references indexed in Scilit:
- Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA–mRNA interactionsMolecular Biology of the Cell, 2013
- Salivary MicroRNAs and Oral Cancer DetectionMethods in molecular biology (Clifton, N.J.), 2012
- Low-Level Expression of miR-375 Correlates with Poor Outcome and Metastasis While Altering the Invasive Properties of Head and Neck Squamous Cell CarcinomasThe American Journal of Pathology, 2012
- Salivary analysis of oral cancer biomarkersBritish Journal of Cancer, 2009
- Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer DetectionClinical Cancer Research, 2009
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screeningGut, 2009
- Salivary Proteomics for Oral Cancer Biomarker DiscoveryClinical Cancer Research, 2008
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences of the United States of America, 2008
- RNAprotect Saliva: An Optimal Room- Temperature Stabilization Reagent for the Salivary TranscriptomeClinical Chemistry, 2006